Editor’s Choice Articles are selected based on suggestions from Cancers’ Academic Editors worldwide. The Editors select a small number of recently published articles that they consider particularly interesting to our readers or important in their respective fields of research. You are welcome to read the Editor’s Choice Articles related to cancer biomarkers, a curated list of high-quality articles from 2022 to 2023 in Cancers (ISSN: 2072-6694). The full list of Editor's Choice Articles can be viewed at the following link: https://www.mdpi.com/journal/cancers/editors_choice. The list of relevant papers can be seen below.

“Energy Sources for Exosome Communication in a Cancer Microenvironment”
by Abhimanyu Thakur, Amanda Johnson, Emily Jacobs, Kui Zhang, Jonathan Chen, Zhubo Wei, Qizhou Lian and Huanhuan Joyce Chen
Cancers 2022, 14(7), 1698; https://doi.org/10.3390/cancers14071698
Available online: https://www.mdpi.com/2072-6694/14/7/1698

“Tumor Cell Infiltration into the Brain in Glioblastoma: From Mechanisms to Clinical Perspectives”
by Fidan Seker-Polat, Nareg Pinarbasi Degirmenci, Ihsan Solaroglu and Tugba Bagci-Onder
Cancers 2022, 14(2), 443; https://doi.org/10.3390/cancers14020443
Available online: https://www.mdpi.com/2072-6694/14/2/443

“The Emerging Impact of Tumor Budding in Oral Squamous Cell Carcinoma: Main Issues and Clinical Relevance of a New Prognostic Marker”
by Lucrezia Togni, Vito Carlo Alberto Caponio, Nicoletta Zerman, Giuseppe Troiano, Khrystyna Zhurakivska, Lorenzo Lo Muzio, Andrea Balercia, Marco Mascitti and Andrea Santarelli
Cancers 2022, 14(15), 3571; https://doi.org/10.3390/cancers14153571
Available online: https://www.mdpi.com/2072-6694/14/15/3571

“The Role of Artificial Intelligence in Early Cancer Diagnosis”
by Benjamin Hunter, Sumeet Hindocha and Richard W. Lee
Cancers 2022, 14(6), 1524; https://doi.org/10.3390/cancers14061524
Available online: https://www.mdpi.com/2072-6694/14/6/1524

“Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer”
by Martín Núñez Abad, Silvia Calabuig-Fariñas, Miriam Lobo de Mena, Susana Torres-Martínez, Clara García González, José Ángel García García, Vega Iranzo González-Cruz and Carlos Camps Herrero
Cancers 2022, 14(2), 307; https://doi.org/10.3390/cancers14020307
Available online: https://www.mdpi.com/2072-6694/14/2/307

“Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer”
by Ulf Gyllensten, Julia Hedlund-Lindberg, Johanna Svensson, Johanna Manninen, Torbjörn Öst, Jon Ramsell, Matilda Åslin, Emma Ivansson, Marta Lomnytska, Maria Lycke et al.
Cancers 2022, 14(7), 1757; https://doi.org/10.3390/cancers14071757
Available online: https://www.mdpi.com/2072-6694/14/7/1757

“Fatty Acid Metabolism in Myeloid-Derived Suppressor Cells and Tumor-Associated Macrophages: Key Factor in Cancer Immune Evasion”
by Sophiya Siddiqui and Rainer Glauben
Cancers 2022, 14(1), 250; https://doi.org/10.3390/cancers14010250
Available online: https://www.mdpi.com/2072-6694/14/1/250

“The Evolution of Ovarian Carcinoma Subclassification”
by Martin Köbel and Eun Young Kang
Cancers 2022, 14(2), 416; https://doi.org/10.3390/cancers14020416
Available online: https://www.mdpi.com/2072-6694/14/2/416

“Peptide Receptor Radionuclide Therapy with [¹⁷⁷Lu]Lu-DOTA-TATE in Patients with Advanced GEP NENS: Present and Future Directions”
by Maria I. del Olmo-García, Stefan Prado-Wohlwend, Pilar Bello, Angel Segura and Juan F. Merino-Torres
Cancers 2022, 14(3), 584; https://doi.org/10.3390/cancers14030584
Available online: https://www.mdpi.com/2072-6694/14/3/584

“Chemotherapy Side-Effects: Not All DNA Damage Is Equal”
by Winnie M. C. van den Boogaard, Daphne S. J. Komninos and Wilbert P. Vermeij
Cancers 2022, 14(3), 627; https://doi.org/10.3390/cancers14030627
Available online: https://www.mdpi.com/2072-6694/14/3/627

“Characterization of Cellular and Acellular Analytes from Pre-Cystectomy Liquid Biopsies in Patients Newly Diagnosed with Primary Bladder Cancer”
by Stephanie N. Shishido, Salmaan Sayeed, George Courcoubetis, Hooman Djaladat, Gus Miranda, Kenneth J. Pienta, Jorge Nieva, Donna E. Hansel, Mihir Desai, Inderbir S. Gill et al.
Cancers 2022, 14(3), 758; https://doi.org/10.3390/cancers14030758
Available online: https://www.mdpi.com/2072-6694/14/3/758

“Innate and Adaptive Immunopathogeneses in Viral Hepatitis; Crucial Determinants of Hepatocellular Carcinoma”
by Marco Y. W. Zaki, Ahmed M. Fathi, Samara Samir, Nardeen Eldafashi, Kerolis Y. William, Maiiada Hassan Nazmy, Moustafa Fathy, Upkar S. Gill and Shishir Shetty
Cancers 2022, 14(5), 1255; https://doi.org/10.3390/cancers14051255
Available online: https://www.mdpi.com/2072-6694/14/5/1255

“Discovery of a New CaMKII-Targeted Synthetic Lethal Therapy against Glioblastoma Stem-like Cells”
by Jang Mi Han, Yu Jin Kim and Hye Jin Jung
Cancers 2022, 14(5), 1315; https://doi.org/10.3390/cancers14051315
Available online: https://www.mdpi.com/2072-6694/14/5/1315

“The Matrisome Is Associated with Metabolic Reprograming in Stem-like Phenotypes of Gastric Cancer”
by Ji-Yong Sung and Jae-Ho Cheong
Cancers 2022, 14(6), 1438; https://doi.org/10.3390/cancers14061438
Available online: https://www.mdpi.com/2072-6694/14/6/1438

“Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management”
by Sukanya Pati, Wadeed Irfan, Ahmad Jameel, Shahid Ahmed and Rabia K. Shahid
Cancers 2023, 15(2), 485; https://doi.org/10.3390/cancers15020485
Available online: https://www.mdpi.com/2072-6694/15/2/485

“Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer”
by Hayato Muranaka, Andrew Hendifar, Arsen Osipov, Natalie Moshayedi, Veronica Placencio-Hickok, Nicholas Tatonetti, Aleksandr Stotland, Sarah Parker, Jennifer Van Eyk, Stephen J. Pandol et al.
Cancers 2023, 15(11), 3020; https://doi.org/10.3390/cancers15113020
Available online: https://www.mdpi.com/2072-6694/15/11/3020

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office